Drug application

LITHIUM CARBONATE (LITHIUM CARBONATE)

Drugs@FDA ANDA 072542 · USL PHARMA

Key facts

Drug name LITHIUM CARBONATE
Active ingredients LITHIUM CARBONATE
Application type ANDA
Application number 072542
Company USL PHARMA
Dosage forms CAPSULE, ORAL
Strength 300MG
Marketing status Discontinued
Reference listed drug No

At a glance

  • None Label versions
  • 1–9 Products
  • None Therapeutic equivalents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA

Browse all Drugs@FDA applications